Sign in

Herpes Cure Advocacy

@herpesadvocate.bsky.social
112 followers 140 following 291 posts

We are a grassroots membership-based, international advocacy organization with a goal of treatment, cure and prevention for Herpes Simplex Virus types 1 + 2. www.herpescureadvocacy.com

PostsRepliesMedia
Herpes Cure Advocacy @herpesadvocate.bsky.social · 05/10/2026
110
Herpes Cure Advocacy @herpesadvocate.bsky.social · 26/09/2026
🧬 Herpes Cure Pipeline 5.0 is coming! We’re taking a look at the latest developments in HSV research, including clinical development, vaccines, antiviral approaches, and future research priorities. Coming early October! 🌐 Visit HCA⁠ #HSV #HerpesCure #HerpesResearch #EndTheStigma
100
Herpes Cure Advocacy @herpesadvocate.bsky.social · 25/09/2026
💜 Living Well with HSV In this video, Dr. Ina Park shares information and perspective on living well with HSV, helping to replace fear and stigma with knowledge and understanding. youtu.be/cPs5yw27vEA?... #HerpesAwareness #HSV #HerpesEducation #EndTheStigma #HerpesCureAdvocacy
youtu.be
Living Well with HSV Dr. Ina Park
YouTube video by Herpes Cure Advocacy
000
Herpes Cure Advocacy @herpesadvocate.bsky.social · 24/09/2026
spfpp.org/podcast/spfp...
spfpp.org
SPFPP 415: Surviving Childhood Trauma, Healing the Inner Child, & Navigating Herpes — Something Positive for Positive People
Our guest shares her story of childhood sexual assault, contracting HSV at age 5, surviving a suicide attempt, and choosing radical self-forgiveness.
000
Herpes Cure Advocacy @herpesadvocate.bsky.social · 22/09/2026
The HSV research landscape keeps moving. 🧬 Since Pipeline 4.0, new developments have emerged across vaccines, antivirals, gene editing & more. What’s changed? Herpes Cure Pipeline 5.0 is coming. 👀 #HSV #HerpesCure #HerpesResearch herpescureadvocacy.com/herpes-simpl...
herpescureadvocacy.com
Herpes Simplex Virus 101: The Basics -
The basics on the prevalence, epidemiology, and public health impact of Herpes Simplex Virus. Prevalence, Demographics, and Data on Herpes Simplex Virus 2018 NCHS Data Brief: Prevalence of Herpes Simp...
000
Herpes Cure Advocacy @herpesadvocate.bsky.social · 05/09/2026
us06web.zoom.us/meeting/regi...
000
Herpes Cure Advocacy @herpesadvocate.bsky.social · 10/08/2026
🎬 Nobody Needs to Know is a short dark comedy about herpes, disclosure, stigma, and navigating difficult conversations after an HSV diagnosis. Written, directed & starring Rachel Rosenstein, the film is inspired by her own experience. Watch the film: www.youtube.com/watch?v=ho-v... #HSV
youtube.com
NOBODY NEEDS TO KNOW | Omeleto
YouTube video by Omeleto
000
Herpes Cure Advocacy @herpesadvocate.bsky.social · 03/08/2026
🚨 Something exciting is on the horizon. The Herpes Cure Advocacy Cure Pipeline is getting its biggest update yet. Stay tuned. 👀 The future of HSV research is moving forward, and we can’t wait to share what’s next. #HerpesCureAdvocacy #HerpesResearch #HSV #HerpesCure gcld.co/PvkWvwZ
gcld.co
Herpes Cure Advocacy -
A grassroots nonprofit for HSV-1 & HSV-2 Advocating the cureEnding the stigma Herpes Cure Advocacy is a volunteer-driven 501(c)(3) accelerating research, education, and policy, working toward a future...
000
Herpes Cure Advocacy @herpesadvocate.bsky.social · 20/07/2026
A new resource for the HSV community 💜 Kind is a dating app created specifically for people living with HSV, with a focus on privacy, safety, and meaningful connections. #HSV #Herpes #EndTheStigma
100
Herpes Cure Advocacy @herpesadvocate.bsky.social · 19/07/2026
Should herpes be part of routine STI screening? Watch HCA Board Member and UCLA researcher Dr. Lao-Tzu Allan-Blitz discuss the latest science and what it could mean for the future of HSV screening. 🎥 youtu.be/WWL9wqQWfKQ?...
youtu.be
Is It Time to Start Screening for Herpes?
YouTube video by Herpes Cure Advocacy
001
Herpes Cure Advocacy @herpesadvocate.bsky.social · 14/04/2026
ICYMI: We hosted Dr. Harvey M. Friedman on April 9 to discuss herpes vaccine development. 🧬 mRNA vaccines targeting multiple proteins 🧪 Strong preclinical results 👩‍🔬 Early human trials show promise Watch the full talk: youtu.be/-vyTRF-8hKE?... #HerpesResearch #HSV2 #STIAwareness
youtu.be
Genital herpes vaccine development, one lab's approach with Dr. Friedman
YouTube video by Herpes Cure Advocacy
020
Herpes Cure Advocacy @herpesadvocate.bsky.social · 09/04/2026
A new dating app called Vela was built by members of the community for people living with HSV, HPV, HIV, and other chronic conditions. Sign up and get verified during the launch month to receive your first month of premium limited to the first 1,000 verified users. Join the waitlist: veladate.app
000
Herpes Cure Advocacy @herpesadvocate.bsky.social · 29/03/2026
New educational talk announcement: Join us for a scientific update with Dr. Harvey Friedman on HSV vaccine research and clinical trial progress. 📅 April 9, 2026 🕒 3:00–4:00 PM ET Register here: us06web.zoom.us/meeting/regi... #HSV #VaccineResearch #PatientAdvocacy
us06web.zoom.us
Welcome! You are invited to join a meeting: Genital herpes vaccine development, one lab's approach with Dr. Friedman. After registering, you will receive a confirmation email about joining the meeting...
Welcome! You are invited to join a meeting: Genital herpes vaccine development, one lab's approach with Dr. Friedman. After registering, you will receive a confirmation email about joining the meeting...
100
Herpes Cure Advocacy @herpesadvocate.bsky.social · 25/03/2026
STI Awareness Week is April 12–18. Start the conversation. Get tested. Reduce stigma. Download the toolkit: www.nationalcoalitionforsexualhealth.org/wp-content/u...
nationalcoalitionforsexualhealth.org
000
Herpes Cure Advocacy @herpesadvocate.bsky.social · 16/03/2026
A new study reports a rise in severe neonatal herpes infections after the COVID-19 pandemic. Researchers identified 62 HSV cases among 632,000+ infants, with an incidence of 9.8 per 100,000 births.  The most severe form of disease increased after 2021. 
nationaltoday.com
Study Finds Rise in Severe Neonatal Herpes Infections After Pandemic - Oakland Today
A new study published in Pediatrics suggests that cases of the most severe form of herpes infection in newborns rose significantly following the COVID pandemic. The findings also indicate that herpes ...
100
Herpes Cure Advocacy @herpesadvocate.bsky.social · 11/03/2026
Terri Warren, RN — one of the leading experts in HSV education — answers important questions about herpes, testing, transmission, and living with HSV in this recording. Education reduces stigma. Accurate information matters. 🎧 Watch here: youtu.be/hQgOwdy6V3U?... #HSV #HerpesEducation #EndTheStig
youtu.be
How Clinicians and Patients Talk about Herpes: Bridging the Disconnect
YouTube video by Herpes Cure Advocacy
010
Herpes Cure Advocacy @herpesadvocate.bsky.social · 03/03/2026
March 5 | 5 PM EST Join us for How Clinicians and Patients Talk About Herpes: Bridging the Disconnect Featuring herpes expert Terri Warren, discussing how patients and clinicians can improve communication in care. Register: lnkd.in/gvXaA2Kf #herpes #livingwithherpes #patientadvocacy #sexualhealt
lnkd.in
LinkedIn
This link will take you to a page that’s not on LinkedIn
000
Herpes Cure Advocacy @herpesadvocate.bsky.social · 28/02/2026
🗓 March 5 | 5 PM EST 💬 How Clinicians and Patients Talk About #Herpes Join Terri Warren, NP (40+ years of herpes care experience), for a powerful conversation on improving patient-provider communication. 🔗 Register: lnkd.in/gvXaA2Kf #LivingWithHerpes #PatientAdvocacy #SexualHealth #FindACure
lnkd.in
LinkedIn
This link will take you to a page that’s not on LinkedIn
000
Herpes Cure Advocacy @herpesadvocate.bsky.social · 21/02/2026
📣 Upcoming Talk — March 5, 5 PM EST How Clinicians & Patients Talk About #Herpes with Terri Warren (40+ years in herpes care) For people living with herpes, loved ones, and clinicians in primary care, ID & SRH.
lnkd.in
LinkedIn
This link will take you to a page that’s not on LinkedIn
100
Herpes Cure Advocacy @herpesadvocate.bsky.social · 11/02/2026
📢 Upcoming Educational Webinar How Clinicians and Patients Talk About Herpes: Bridging the Disconnect Despite HSV’s prevalence, many patients face stigma, limited education, and gaps in care. 📅 March 5 | 5–6 PM EST 🔗 Register: us06web.zoom.us/meeting/regi...
us06web.zoom.us
Welcome! You are invited to join a meeting: Challenges in Clinical Care with Terri Warren. After registering, you will receive a confirmation email about joining the meeting.
Welcome! You are invited to join a meeting: Challenges in Clinical Care with Terri Warren. After registering, you will receive a confirmation email about joining the meeting.
000
Herpes Cure Advocacy @herpesadvocate.bsky.social · 11/02/2026
Phase 1B data presented by Dr. Grace Wang showed promising reductions in viral shedding and outbreaks for investigational long-acting HSV therapies. Science is moving — and HSV research continues to progress. youtu.be/MGhR42Ka2KM?... #Virology #LongActingTherapies #MedicalScience #EndTheStigma
youtu.be
Assembly Bio: Redefining the Treatment of Recurrent Genital Herpes Through Long-Acting Innovation
YouTube video by Herpes Cure Advocacy
000
Herpes Cure Advocacy @herpesadvocate.bsky.social · 05/02/2026
🔴 DAY OF EVENT TODAY is the day. Join us for an exclusive scientific discussion with Assembly Bio on advancing long-acting treatments for recurrent genital herpes.
us06web.zoom.us
Welcome! You are invited to join a meeting: Assembly Bio: Redefining the Treatment of Recurrent Genital Herpes Through Long-Acting Innovation.. After registering, you will receive a confirmation email...
Welcome! You are invited to join a meeting: Assembly Bio: Redefining the Treatment of Recurrent Genital Herpes Through Long-Acting Innovation.. After registering, you will receive a confirmation email...
100
Herpes Cure Advocacy @herpesadvocate.bsky.social · 04/02/2026
🚀 1 DAY BEFORE Tomorrow. We go deep into the science shaping the future of recurrent genital herpes treatment. Join us for: 🧬 Clinical trial insights 💊 Long-acting therapy development 📈 Phase 2 outlook
us06web.zoom.us
Welcome! You are invited to join a meeting: Assembly Bio: Redefining the Treatment of Recurrent Genital Herpes Through Long-Acting Innovation.. After registering, you will receive a confirmation email...
Welcome! You are invited to join a meeting: Assembly Bio: Redefining the Treatment of Recurrent Genital Herpes Through Long-Acting Innovation.. After registering, you will receive a confirmation email...
100
Herpes Cure Advocacy @herpesadvocate.bsky.social · 03/02/2026
🔬 2 DAYS BEFORE In 48 hours, we’re talking about the real impact of recurrent genital herpes—and how science is working toward better solutions. From epidemiology to patient experience to the next wave of antiviral development, this session is a must-attend.
us06web.zoom.us
Welcome! You are invited to join a meeting: Assembly Bio: Redefining the Treatment of Recurrent Genital Herpes Through Long-Acting Innovation.. After registering, you will receive a confirmation email...
Welcome! You are invited to join a meeting: Assembly Bio: Redefining the Treatment of Recurrent Genital Herpes Through Long-Acting Innovation.. After registering, you will receive a confirmation email...
100
Herpes Cure Advocacy @herpesadvocate.bsky.social · 02/02/2026
⏰ 3 DAYS BEFORE 3 days to go until we spotlight cutting-edge research in recurrent genital herpes. Dr. Grace Wang, VP of Clinical Development at Assembly Biosciences, will present on: • ABI-5366 • ABI-1179 • The future of long-acting HSV therapies
us06web.zoom.us
Welcome! You are invited to join a meeting: Assembly Bio: Redefining the Treatment of Recurrent Genital Herpes Through Long-Acting Innovation.. After registering, you will receive a confirmation email...
Welcome! You are invited to join a meeting: Assembly Bio: Redefining the Treatment of Recurrent Genital Herpes Through Long-Acting Innovation.. After registering, you will receive a confirmation email...
100
Herpes Cure Advocacy @herpesadvocate.bsky.social · 29/01/2026
New video: Herpes Cure Pipeline 4.0 (2025) 🎥 An in-depth look at emerging treatments, long-acting innovations, and scientific progress toward a cure for HSV. Watch now: youtube.com/watch?v=lGD6... #HerpesCure #HSV #HerpesResearch #ClinicalTrials #CureForHerpes
youtube.com
Herpes Cure Pipeline 4.0 2025
YouTube video by Herpes Cure Advocacy
000
Herpes Cure Advocacy @herpesadvocate.bsky.social · 28/01/2026
Did you know that long-acting antiviral therapies are being developed to transform how recurrent genital herpes is treated? On February 5th, we’re hosting Assembly Biosciences for a deep dive into: 🔬 Emerging long-acting HSV treatments 📊 Clinical trial findings 🧠 The future of patient care
us06web.zoom.us
Welcome! You are invited to join a meeting: Assembly Bio: Redefining the Treatment of Recurrent Genital Herpes Through Long-Acting Innovation.. After registering, you will receive a confirmation email...
Welcome! You are invited to join a meeting: Assembly Bio: Redefining the Treatment of Recurrent Genital Herpes Through Long-Acting Innovation.. After registering, you will receive a confirmation email...
100
Herpes Cure Advocacy @herpesadvocate.bsky.social · 21/01/2026
New HCA-Supported Research 🔬 Published in the International Journal of STD & AIDS, this study explores whether a history of genital herpes symptoms predicts HSV-2 antibody positivity.
pubmed.ncbi.nlm.nih.gov
Does genital herpes symptom history predict herpes simplex virus type 2 antibody positivity? - PubMed
With currently available tests, recommendations to screen individuals based on genital herpes symptom history may not be useful. More discriminatory symptom screening tools or HSV-2 antibody tests with better performance are needed.
120
Herpes Cure Advocacy @herpesadvocate.bsky.social · 21/01/2026
New HCA-Supported Research 🧬 A review published in the Journal of the Pediatric Infectious Diseases Society analyzes how neonatal herpes is reported across U.S. states and reveals significant gaps and inconsistencies in current policies.
pubmed.ncbi.nlm.nih.gov
Neonatal Herpes Reporting in the United States: Review of Current Policies by State - PubMed
Despite its devastating impact, neonatal herpes is not a nationally notifiable condition. As of 2023 it is only reportable in 6 states. A consistently applied case definition with designation as a nationally notifiable condition would optimize surveillance and preventative efforts.
100
Herpes Cure Advocacy @herpesadvocate.bsky.social · 21/01/2026
New HCA-Supported Research 📊 A recent study in Sexually Transmitted Diseases examines patterns of congenital syphilis in a large public hospital, highlighting key maternal risk factors and infant outcomes.
pubmed.ncbi.nlm.nih.gov
Patterns of Congenital Syphilis in a Large Public Hospital: Maternal Risk Factors and Infant Outcomes - PubMed
This case series identified maternal substance use and no prenatal care as risk factors for highly probable or possible CS, underscoring the vulnerability of this population and informing future work in prevention of this disease.
100
Herpes Cure Advocacy @herpesadvocate.bsky.social · 17/01/2026
youtube.com/watch?v=Wahe...
youtube.com
From Discovery to Cure: Understanding the Complex Path of (Antiherpetic) Drug Development.
YouTube video by Herpes Cure Advocacy
000
Herpes Cure Advocacy @herpesadvocate.bsky.social · 17/01/2026
New HCA-Supported Research 📄 We’re proud to highlight a new systematic review protocol examining the association between HSV-1 and dementia, published in BMJ Open.
pubmed.ncbi.nlm.nih.gov
Association between herpes simplex virus 1 and dementia: a systematic review protocol - PubMed
CRD42024516789.
100
Herpes Cure Advocacy @herpesadvocate.bsky.social · 13/01/2026
🔔Starting in 1 hour ⏳ From discovery to cure: the complex path of antiherpetic drug development 🎤 Luis Schang, MV, PhD Join us live at 6pm EST. 🔗 us06web.zoom.us/meeting/regi...
us06web.zoom.us
Welcome! You are invited to join a meeting: HCA: From discovery to cure. After registering, you will receive a confirmation email about joining the meeting.
Welcome! You are invited to join a meeting: HCA: From discovery to cure. After registering, you will receive a confirmation email about joining the meeting.
000
Herpes Cure Advocacy @herpesadvocate.bsky.social · 13/01/2026
🔔 DAY OF Today’s the day. From discovery to cure: the complex path of antiherpetic drug development 🎤 Luis Schang, MV, PhD 🕕 6:00pm EST Last chance to register: 🔗 : us06web.zoom.us/meeting/regi...
us06web.zoom.us
Welcome! You are invited to join a meeting: HCA: From discovery to cure. After registering, you will receive a confirmation email about joining the meeting.
Welcome! You are invited to join a meeting: HCA: From discovery to cure. After registering, you will receive a confirmation email about joining the meeting.
000
Herpes Cure Advocacy @herpesadvocate.bsky.social · 12/01/2026
🔔 1 DAY OUT Goal: Urgency ⏰ Tomorrow! Join HCA for our first educational talk of 2026: From discovery to cure: the complex path of antiherpetic drug development 🎤 Luis Schang, MV, PhD 🗓 Jan 13 | 6pm EST
us06web.zoom.us
Welcome! You are invited to join a meeting: HCA: From discovery to cure. After registering, you will receive a confirmation email about joining the meeting.
Welcome! You are invited to join a meeting: HCA: From discovery to cure. After registering, you will receive a confirmation email about joining the meeting.
100
Herpes Cure Advocacy @herpesadvocate.bsky.social · 10/01/2026
herpescureadvocacy.com/event/from-d...
herpescureadvocacy.com
From discovery to cure: the complex path of antiherpetic drug development
We frequently hear about breakthrough discoveries and promising results for new antiherpetic drugs, only to hear nothing more about them afterward. Promising therapies are announced, followed by lo…
000
Herpes Cure Advocacy @herpesadvocate.bsky.social · 10/01/2026
🔔 3 DAYS OUT Goal: Audience expansion + sharing If you’re involved in research, healthcare, or advocacy around herpes, this is a session you won’t want to miss.
us06web.zoom.us
Welcome! You are invited to join a meeting: HCA: From discovery to cure. After registering, you will receive a confirmation email about joining the meeting.
Welcome! You are invited to join a meeting: HCA: From discovery to cure. After registering, you will receive a confirmation email about joining the meeting.
100
Herpes Cure Advocacy @herpesadvocate.bsky.social · 08/01/2026
🔔 5 DAYS OUT! In our upcoming HCA talk, Dr. Luis Schang will break down: • Why “promising” therapies stall • Where bottlenecks occur • How antivirals like valacyclovir made it through — and why others struggle 🗓 Jan 13 | 6pm EST 🔗 Register: us06web.zoom.us/meeting/regi...
us06web.zoom.us
Welcome! You are invited to join a meeting: HCA: From discovery to cure. After registering, you will receive a confirmation email about joining the meeting.
Welcome! You are invited to join a meeting: HCA: From discovery to cure. After registering, you will receive a confirmation email about joining the meeting.
000
Herpes Cure Advocacy @herpesadvocate.bsky.social · 07/01/2026
We often hear about promising antiherpetic drugs… then nothing. Why does that happen? Where are the bottlenecks? Join HCA on Jan 13 at 6pm EST for a deep dive into the antiviral development pipeline with Luis Schang, MV, PhD — from lab discovery to clinical approval, with real HSV case studies.
100
Herpes Cure Advocacy @herpesadvocate.bsky.social · 20/12/2025
Research is advancing. Clinical trials are progressing. A herpes cure is no longer a distant idea — it’s a real scientific pursuit.
000
Herpes Cure Advocacy @herpesadvocate.bsky.social · 20/12/2025
We are closer to a herpes cure than ever before — and funding matters. ✨ Every gift fuels research awareness ✨ Every share fights stigma ✨ Every dollar brings us closer to a cure Give hope before the year ends. herpescureadvocacy.com/ways-to-give/ donatestock.com/herpes-cure-...
herpescureadvocacy.com
Ways to Give
Ways to Give At Herpes Cure Advocacy (HCA), we believe that every contribution, regardless of size, makes a meaningful difference in advancing our mission. We’ve made it easy for you to suppo…
010
Herpes Cure Advocacy @herpesadvocate.bsky.social · 09/12/2025
Major update in HSV-2 research👇 Assembly Biosciences just released Phase 1b results showing: • 91% fewer confirmed lesions • 76–94% reduction in viral shedding • 99%+ drop in high-viral-load samples
100
Herpes Cure Advocacy @herpesadvocate.bsky.social · 02/12/2025
This #GivingTuesday, we’re fighting stigma and pushing for real progress toward an HSV cure. Give today: herpescureadvocacy.com/ways-to-give/
herpescureadvocacy.com
Ways to Give
Ways to Give At Herpes Cure Advocacy (HCA), we believe that every contribution, regardless of size, makes a meaningful difference in advancing our mission. We’ve made it easy for you to suppo…
010
Herpes Cure Advocacy @herpesadvocate.bsky.social · 23/10/2025
Did you miss our #herpesawarenessday talk on better testing for #herpes? We have it recorded and you can find it and all our other educational talks on our website under Recorded Talks! Have a topic you're interested in learning more of? Let us know! herpescureadvocacy.com/recorded-tal...
herpescureadvocacy.com
Recorded Talks
Herpes Cure Advocacy hosts monthly meetings covering a wide range of HSV related topics. We understand not everyone is able to attend the talks live, so we’ve created this page as a resource …
010
Herpes Cure Advocacy @herpesadvocate.bsky.social · 12/10/2025
More good news from AssemblyBio who expects to initiate phase 2 of ABI-5366 in mid 2026! investor.assemblybio.com/news-release...
investor.assemblybio.com
100
Herpes Cure Advocacy @herpesadvocate.bsky.social · 12/10/2025
Did you know tomorrow is National #Herpes Awareness Day? In honor of it, we are hosting a talk with Dr. Camerini on the Development of Better Serological Tests for Herpes. We hope you join us! herpescureadvocacy.com/event/develo...
herpescureadvocacy.com
Development of Better Serological Tests for HSV-1 and HSV-2 Infections with David Camerini
David Camerini is the Director of Virology at ImmPORT Therapeutics/DBA Antigen Discovery Register Here
000
Herpes Cure Advocacy @herpesadvocate.bsky.social · 07/10/2025
herpescureadvocacy.com/event/therap...
herpescureadvocacy.com
Therapy and prevention of long-term cognitive impairment following neonatal herpes simplex virus infections
Advancing Science is a meeting series in a partnership between Herpes Cure Advocacy and HVTN to highlight the latest science in herpes, projects that are driving the field of HSV research forward a…
000
Herpes Cure Advocacy @herpesadvocate.bsky.social · 02/10/2025
It’s spooky season! And we have a some great events for you this month! Next week, Dr. David Leib will give a talk on neonatal herpes! More info below: herpescureadvocacy.com/event/therap...
herpescureadvocacy.com
Therapy and prevention of long-term cognitive impairment following neonatal herpes simplex virus infections
Advancing Science is a meeting series in a partnership between Herpes Cure Advocacy and HVTN to highlight the latest science in herpes, projects that are driving the field of HSV research forward a…
000
Reposted by Herpes Cure Advocacy
Junji Xing @junjixing.bsky.social · 18/09/2025
Herpes Simplex Virus 1-Encoded Tegument Protein VP16 Abrogates the Production of Beta Interferon (IFN) by Inhibiting NF-κB Activation and Blocking IFN Regulatory Factor 3 To Recruit Its Coactivator CBP | Journal of Virology journals.asm.org/doi/10.1128/... @asm.org @herpesadvocate.bsky.social
journals.asm.org
Herpes Simplex Virus 1-Encoded Tegument Protein VP16 Abrogates the Production of Beta Interferon (IFN) by Inhibiting NF-κB Activation and Blocking IFN Regulatory Factor 3 To Recruit Its Coactivator CBP | Journal of Virology
ABSTRACT Host cells activate innate immune signaling pathways to defend against invading pathogens. To survive within an infected host, viruses have evolved intricate strategies to counteract host immune responses. Herpesviruses, including herpes simplex ...
021
Herpes Cure Advocacy @herpesadvocate.bsky.social · 16/09/2025
Aicuris Announces Upcoming Oral and Poster Presentations at ID Week 2025. The company will provide an overview of the pritelivir clinical development program in two oral presentations including a comprehensive Phase 2 data overview. #herpes www.biospace.com/press-releas...
biospace.com
Aicuris Announces Upcoming Oral and Poster Presentations at ID Week 2025
000